Skip to main content
OpenTrials
Completed

NCT Number: NCT03274622

Efficacy of IMPACT in Infant Siblings of Children With ASD

Over a 5 year period infant and baby siblings of children with autism spectrum disorders (ASD) will be recruited to this study and will be randomized into 2 groups. Parents of the intervention group will receive 12 weeks of coaching in how to implement this intervention. Parents randomized to the control group will not receive intervention coaching. Both groups will attend a series of clinic appointments for data collection that occur at 3 month intervals over a 9 month period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 month–18 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vanderbilt University, Nashville, Tennessee, United States

Loading trial locations.

About this study

This two-site randomized controlled trail (RCT) will include a sample of 80 siblings of children with ASD (Sibs-ASD) (11 months, 15 days to 18 months, 15 days) who are stratified on initial cumulative-risk status for communication disorder and then randomly assigned to Ingersoll's Improving Parents As Communication Teachers (ImPACT; Ingersoll & Dvortcsak, 2010) treatment or to a business-as-usual (BAU) control condition. The following hypotheses will be tested:

  • Compared to the BAU Control, children assigned to the ImPACT group will show (a) more growth on pivotal skills and language level, and (b) a lesser degree of ASD symptomatology and language delay.
  • Pretreatment, cumulative-risk level will statistically interact with (i.e., moderate) treatment assignment to predict children's (a) change in pivotal skills and language, and (b) severity of autism symptoms and language delay.
  • Compared to the BAU Control, parents in ImPACT will have more optimal parenting stress and parenting efficacy, at least in parents with average or below average depressive symptoms prior to treatment (i.e., depressive symptoms will moderate the effect of ImPACT on parental stress and parenting efficacy).
  • The effect that ImPACT has on growth of pivotal skills and language will be mediated by parents' frequency and fidelity of use of ImPACT strategies at immediate post-treatment.
  • The effect of ImPACT on degree of children's language delay and ASD symptomatology at 6 months post-treatment will be mediated by their pivotal skill level at 3 months post-treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Younger sibling of a child with ASD -

  • Age: 11 months, 15 days to 18 months, 15 days
  • Older biological sibling: Must have a diagnosis of Autism from UW or VU, which is confirmed via record review. If the older sibling was not diagnosed at UW or VU, then a diagnostic appointment must be made for the older sibling at the corresponding institution in order to confirm the diagnosis of ASD. Half-siblings are ok.
  • Vision - WNL corrected
  • Hearing - WNL corrected
  • Motor: The child must be able to sit independently while picking up objects and giving them to another person.

Exclusions:

No primary motor impairment. No feeding tubes. No other neurological or genetic conditions. Primary language exposure: The primary parent speak to the child using English 50% of the time, and process.

Treatment and study plan

Impact Parent Training

Behavioral

No Impact

Behavioral

Primary outcomes

  1. Growth in communication

    Time frame: Change between baseline and 9 months after entry

    weighted frequency of intentional communication from the Communication and Symbolic Behavior Scale, high is good range is 0 - 400

Secondary outcomes

  1. Growth in play

    Time frame: Change from Baseline to 9 months after entry

    raw scores from Developmental Play Assessment, high is good, range is 0 to 50

  2. Motor imitation

    Time frame: Change from Baseline to 9 months after entry

    raw scores from the Structured Social Imitation Scale, high is good, range 0 - 50

  3. Autism social affect symptomatology

    Time frame: 9 months after entry

    average of z score from raw scores from Communication and Symbolic Behavior Scale and Autism Diagnositic Observation Schedule (reflected) if they are correlated > .4, after reflection high is good, -4 to 4

  4. Language delay

    Time frame: 9 months after entry

    average of z scores from standard scores or percentile rankings from MacAuthur Communication Development Index and Mullen Scale of Early Learning if they are correlated above .4, high is good, range is -4 to 4

  5. language level

    Time frame: Change from baseline to 9 mos after treatment ends

    average of time 4-referenced z scores from raw scores from Communication and Symbolic Behavior Scales, Brief Observation of Social Communication Change, and MacArthur Communication Development Index if they are correlated above .4, High is good, -4 to 4

  6. parent implementation of ImPACT treatment

    Time frame: change from baseline to immediately post-treatment

    fidelity of treatment of aspects of ImPACT treatment from PCS and PCFP

Sponsors and collaborators

Lead sponsor

Vanderbilt University

Other

Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

Registry information

Official study title

Efficacy of Parent-implemented Treatment in Infant Siblings of Children With Autism Spectrum Disorder (ASD)

Acronym: IMPACT

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Sep 7, 2017
Registry last updated
Oct 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.